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Introduction
Aging is associated with endocrine changes that compromise metabolic balance and result in a progressive catabolism, especially in muscle and bone, while, in parallel, the adipose tissue increases. Nutrition may also become compromised with aging and specific nutrient requirements may not be met. Various conditions, such as growth hormone deficiency, sex-steroid-hormone deficiency, hypothyroidism, insulin resistance, immune deficiency or autoimmunity, inflammatory states, osteoporosis, sleep or psychiatric disturbances, chronic psychological stress, malabsorption, and liver and kidney disease, are often overlooked in terms of nutritional balance resulting in aggravated bodily functioning and in the establishment of biochemical defects that threaten cell structural and functional integrity. In addition, nutritional imbalances may also affect psycho-neuronal function, work performance and social behavior. No comprehensive guidelines for assessment of nutritional status have been developed to facilitate the treatment of elderly patients facing endocrine or metabolic challenges.
decreased bone mineral density, impaired lipid profile and compromised quality of life. Growth hormone treatment may reverse these effects, at least partially [1] .
Menopause is associated with marked hormonal changes with well-known influences on bone homeostasis and general health of women. Similarly, 'andropause' is characterized by reduced sexual desire and erectile function, fatigue, depression, decrease in intellectual activity, skin alterations and decrease in body hair. In addition, testosterone decline, between the ages of 35 and 75, is associated with loss of muscle mass, doubling of fat mass and decrease in bone mineral density. Primary testicular failure and changes at the hypothalamopituitary level contribute to these age-associated changes [2,3]. Diabetes mellitus, cardiovascular disease, hypertension, tobacco and alcohol use, malnutrition or obesity may aggravate testosterone decrease. In addition, hypogonadotrophic hypogonadism is frequent in acute severe illness [4] . An increase in sexhormone-binding globulin with age may result in reduced free testosterone even if total levels remain unchanged. Testosterone supplementation may inhibit adipogenesis, enhance muscle protein turnover and maintain bone mineral density in elderly men [5] .
The hypothalamic-pituitary-adrenal (HPA) axis is also affected by aging. Growth hormone regulates cortisol metabolism by affecting the activity of 11bhydroxysteroid dehydrogenase type 1. Growth hormone supplementation resulted in a significant increase in mean serum dehydroepiandrosterone sulfate (DHEAS) only in corticotropin ('ACTH')-sufficient patients consistent, as pointed by Isidori et al.
[6], with either growth hormone stimulation of adrenal androgen production (in the permissive presence of corticotropin) or an inhibitory effect of growth hormone on 11b-hydroxysteroid dehydrogenase type 1 activity leading to enhanced cortisol clearance, subsequent activation of the HPA axis and corticotropin-mediated androgen secretion. In either case, these conclusions are consistent with the fact that DHEAS and insulin-like growth factor-I (IGF-I) levels decrease while cortisol levels increase with age. Furthermore, IGF-I was correlated to DHEAS levels. DHEAS and IGF-I levels were correlated with bone density T-scores, while DHEAS levels were negatively correlated with levels of interleukin (IL) 6 (a cytokine mediator of bone resorption) [7] . Patients with Alzheimer's disease have higher cortisol and IGF-binding protein (IGFBP) 1 levels and lower DHEAS, total IGF-I and IGFBP-3 levels than controls. IGF-I and IGFBP-3 levels were negatively correlated with the cortisol/DHEAS ratio, and the IGF-I/IGFBPs ratios were negatively correlated with mean cortisol levels. IGFBP-3 correlated directly with DHEAS. Cortisol was positively and IGF-I negatively correlated with cognitive impairment, a fact consistent with the neurotoxic effects of excess cortisol on hippocampal neurons [8] . These observations are consistent with the effects of glucocorticoids on IGF-I production and activity (the latter by modifying IGFBPs) and with the antiglucocorticoid and neuroprotective effects of DHEAS.
Effects on immune-system status and insulin sensitivity
Aging is accompanied by immune activation expressed by increasing levels of inflammatory cytokines, including IL-6, tumour necrosis factor-a (TNF-a) and IL-1b. Higher inflammatory activation is associated with increased risk of functional impairment [9 ] .
Cytokines may inhibit testosterone secretion via central and peripheral effects on the hypothalamic-pituitarytesticular axis. Soluble IL-6 receptor (sIL-6R; a soluble part of the IL-6 receptor molecule that may enhance the biological activity of IL-6) was significantly and inversely correlated with total and free testosterone. No correlation of testosterone with IL-6, TNF-a, IL-1b and C-reactive protein (CRP) was observed [10 ] . Estrogen deficiency leads to increased production of TNF-a. This is mediated by increased interferon-g production by helper T-cells, which, through increased expression of major histocompatibility complex class II molecules on antigen-presenting cells, enhances the activation and proliferation of TNF-a-producing T-cells. TNF-a increases osteoclast formation and bone resorption directly and by augmenting the sensitivity of maturing osteoclasts to the receptor activator of nuclear factor-kB (NF-kB) ligand (RANKL). The protective estrogen effect is mediated by transforming growth factor-b, which blocks T-cell activation and T-cell TNF-a production by repressing antigen presentation [11, 12] .
In addition TNF-a excess in inflammatory states, such as inflammatory bowel disease and arthritis, results in reduced DNA binding of the vitamin D receptor and retinoid X receptor and inhibition of vitamin D-dependent gene expression in osteoblasts [13] . This is mediated by activation of NF-kB, which dissociates from inhibitory kB-a (a NF-kB cytoplasmic inhibitor) and translocates to the nucleus. Vitamin D analogues inhibit the TNF-a-stimulated activation and nuclear translocation of NF-kB and degradation of inhibitory kB-a in immune cells of patients with inflammatory bowel disease [14, 15 ] . It has been suggested that when serum 25-hydroxyvitamin D 3 [25(OH)D3] levels fall below 30 nM, extra-renal 25(OH)D-1a-hydroxylase activity is critically limited due to substrate paucity, resulting in local 1,25-dihydroxyvitamin D 3 [1,25(OH)2D3] insufficiency which predisposes to chronic inflammatory and autoimmune diseases, such as insulin-dependent diabetes mellitus, inflammatory bowel disease and multiple sclerosis, as well as to malignancies such as colon, breast and prostate cancers [16] .
In elderly subjects with zinc deficiency, susceptibility to infections, cell-mediated immune dysfunction and increased oxidative stress have been also observed. After zinc supplementation, the incidence of infections, TNF-a and markers of oxidative stress were significantly lower [17 ] . TNF-a exposure significantly increased nuclear NF-kB-and activator protein-1-binding activities, which were lowered considerably when endothelial cells (previously cultured in zinc-deficient media to deplete cellular zinc stores) were supplemented with physiological levels of zinc [18] . Furthermore, zinc inhibited TNFa-induced NF-kB activation ex vivo, as well as increased A20 mRNA (A20 is a transcription factor that inhibits the activation of NF-kB) and A20 DNA-specific binding in vitro [19] .
Immune-system activation may shift bone and muscle metabolism to a catabolic state possibly promoted by insulin insensitivity associated with various inflammatory markers. Subjects with more severe insulin resistance are older, with higher serum levels of TNF-a, interleukin receptor antagonist (IL-1Ra), and IL-6 and lower levels of sIL-6R. Higher serum IL-6 was associated independently with more severe and sIL-6R with less severe insulin resistance [20] . Plasma TNF-a receptors (sTNFRs) 1 and 2 were substantially higher in groups of obese subjects compared with lean controls and were inversely related to insulin sensitivity [21] . Decreased plasma DS-TNFR2 (a differentially spliced form of sTNFR2 reported to antagonize TNF-a activity) was associated with glucose intolerance or type 2 diabetes mellitus and tended to be associated with fasting and postload glucose and HbA1c. Subjects with two or more components of the metabolic syndrome had circulating DS-TNFR2 levels decreased by almost half [22] . Interestingly, patients with Alzheimer's disease show increased TNF-a, decreased IGF-I and a significant negative correlation between TNF-a and free IGF-I serum levels [23 ] . In addition, the impaired insulin, IGF-I and IGF-II central-nervous-system signaling in patients with Alzheimer's disease results in deficient glucose and energy metabolism and chronic oxidative stress [24] . Insulin resistance has been independently associated with frontal cortex executive dysfunction in older subjects without diabetes mellitus or dementia [25] . These results point at a possible involvement of TNF-a pathways in the deregulation of the IGF-I axis associated with the development of insulin resistance and cognitive impairment.
Effects of aging on bone and muscle physiology
After the age of 40, bone may be lost at a rate of 0.2-0.5% per year in both men and women. Endocrine changes, nutrition, body weight, exercise levels, the overall level of somatic and psychological health and genetic predisposi-tion influence the rate of bone loss, which increases to 2-5% annually around menopause but can be reduced by hormone-replacement therapy. In men and older women (beyond 10 years after the menopause) nutritional deficiencies are critical for osteoporosis.
Effects of sex-steroid, vitamin D and mineral deficiencies on bone metabolism
Osteoclasts that derive from bone marrow mononuclear cells are particularly sensitive to immune-system-derived messages, primarily cytokines. Even small alterations in cytokines, hormones or other signals may modulate the activity of the RANK/RANKL/osteoprotegerin system, contributing to systemic (or local) bone loss and increasing the risk of fracture [26] . During chronic illness, increased levels of inflammatory cytokines shift the balance between bone formation and bone resorption in favor of the latter. Osteopenia, osteoporosis or even decreased linear growth (before and during puberty) and lower peak bone mass are often associated with chronic diseases [27] . Furthermore, it has been postulated that fracture risk might be primed during intrauterine life, early postnatal life or infancy possibly through modulation of the basal activity of endocrine systems such as the growth hormone-IGF-1 and parathyroid hormone (PTH)-vitamin D axes [28] .
Impairment of calcium absorption is associated with several abnormalities of the vitamin D axis, such as secondary hyperparathyroidism, intestinal resistance to 1,25(OH)2D3 action, decreased 1,25(OH)2D3 production due to impaired 25(OH)D-1a-hydroxylase activity and nutritional paucity in vitamin D. In an urban population with osteopenia or osteoporosis, the prevalence of 25(OH)D3 deficiency was 30.5% and that of 25(OH)D3 insufficiency was 35.9%. Interestingly, 25(OH)D3 deficiency was equally frequent in younger and older patients [29] . In the absence of vitamin D supplementation, hypovitaminosis is common in children, even in populations with adequate sun exposure [30] . Furthermore, among patients with primary hyperparathyroidism, vitamin D levels were lower in groups with more severe clinical and biochemical manifestations [31] . Vitamin D deficiency and elevated PTH (due also to selective calcium malabsorption regardless of vitamin D status) are common following gastric bypass surgery for morbid obesity [32 ,33 ] .
Estrogen deficiency intensifies the impairment of intestinal calcium absorption and contributes to bone loss.
Ovariectomy studies in rats have shown that estrogen action, allowing sufficient PTH and 1,25(OH)2D3 activities and renal vitamin D receptor expression, is essential for competent adaptation to a low-calcium diet. Interestingly, the induction of intestinal calcium transporter-1 and calbindin-D9k mRNA expression by low-calcium diet was not altered by ovariectomy [34] . A lack of a direct effect of either estrogen deficiency (ovariectomy) on calcium-sensing receptor (CaSR) mRNA expression or androgen deficiency (orchidectomy) on calcium-sensing receptor and vitamin D receptor mRNA expression in duodenal mucosa has been reported, although both conditions result in decreased intestinal calcium absorption [35, 36] .
Interestingly, only half of patients with vitamin D deficiency were found to have secondary hyperparathyroidism [37] . This insufficient PTH response may be related to magnesium deficiency because women in the low-vitamin D and low-PTH group showed evidence of magnesium depletion. Following oral magnesium supplementation, increases in calcium, PTH and bone turnover were observed [38 ] . Furthermore, as reviewed by Lowe et al. [39] , subclinical zinc and/or copper deficiency due to a reduced dietary intake or reduced absorption may contribute to bone loss in the elderly. Zinc and copper are cofactors for enzymes important for the synthesis of bone matrix components. Due to inhibition of absorption of zinc and impairment of retention of copper, calcium supplementation may aggravate zinc and copper deficiency [39] . In addition, zinc intake was negatively correlated with urinary pyridinoline and deoxypyridinoline but was not correlated with markers of bone formation. There was a tendency for serum zinc to be negatively correlated with urinary deoxypyridinoline while erythrocyte zinc was negatively correlated with serum osteocalcin [40] . The decreased bone growth and mass, decreased thickness of the overall growth plate and hypertrophic cartilage observed in rats on a zincdeficient diet are likely to be mediated by impairment of the IGF-I system, whereas an effect on bone resorption was not observed [41] .
Effects of physical activity and resistance training in muscle and bone physiology
Skeletal-muscle protein and function decline with aging but the relevant pathophysiology is unclear. Interestingly, a positive association between serum IL-6, TNF-a and CRP and incident mobility limitation, which was strengthened when multiple inflammatory markers were high, has been reported. In a subset of patients sIL-2R and sTNFR1 were also positively associated with incident mobility limitation [42] . TNF-a is minimally expressed in normal muscle but it is elevated in various metabolic conditions characterized by muscle wasting and insulin resistance. Muscle immobilization in paretic legs of stroke patients (a group with substantial muscular atrophy and high prevalence of insulin resistance and diabetes mellitus) resulted in significantly higher muscle TNF-a mRNA levels compared with nonparetic legs of control subjects [43] . In contrast, higher levels of exercise were negatively correlated with serum/plasma levels of CRP, IL-6 and TNF-a. These correlations were partially weakened after correction for body fat content. Among nonexercisers, higher levels of other physical activity were related to lower levels of CRP (but not TNF-a), even after adjustment for body fat content. In addition, CRP and IL-6 concentrations were lower in those taking antioxidant supplements regardless of exercise level [44] . The hypothesis that improvement in muscle strength may be limited by systemic low-grade inflammation was supported by the demonstration that plasma sTNFR1 at baseline was inversely correlated with muscle-strength increase in nursing-home residents after a 12-week resistance-training programme, while plasma levels of sTNFR1, TNF-a or IL-6 were not affected [45] . Skeletal-muscle TNF-a mRNA and protein levels were elevated in elderly men and women compared to young men and women. Muscle biopsies from the elderly subjects before and after a 3-month training regime showed that muscle TNF-a mRNA and protein levels decreased only in the exercise group in which muscle protein synthesis was inversely related to TNF-a protein levels [46] . These results are consistent with the findings of a study of obese women with either normal or impaired glucose tolerance (the latter were markedly more insulin resistant and had higher plasma TNF-a and sTNFR2 concentrations than the former). A 12-week aerobic training programme increased insulin sensitivity and decreased TNF-a and sTNFR2 levels in both groups, whereas sTNFR1 remained unchanged. The decrease in sTNFR2 was significantly related to the increase in insulin sensitivity even after correction for anthropometric and biochemical parameters [47] .
Apart from muscle growth, physical activity improves postural stability and consequently results in a reduced rate of accidental falls. In addition, mechanical loading increases bone mass, an effect that is also dependent on a appropriate diet. As reviewed by Murphy and Carroll [48] several recent meta-analytical reviews estimate exerciseinduced gains in bone mass to be in the range of 2-3%. Calcium intake may influence the effect of physical activity on bone allowing greater effects to occur in calcium-replete subjects while physical activity may allow better adaptation to low calcium intake [48] .
Endocrine, immune and nutritional assessment
Based on the above observations, aging appears associated with endocrine deficiencies developed around a compromised state of immune function and inflammation. As reviewed by Hertoghe [49] , desynchronization of hormonal secretion makes hormone activities peak at inappropriate times, becoming inefficient and leading to signs, symptoms and diseases (including cardiovascular diseases, cancer, obesity, diabetes mellitus, osteoporosis and dementia) that accompany human senescence. In this context, diagnosis is difficult because hormonal deficiencies, which often occur as part of circadian rhythms, as well as nutritional imbalances and dietary, behavioral, lifestyle and environmental aberrations (including exposure to sunlight or artificial light, environmental contaminants or endocrine disruptors), would all have to be assessed. Furthermore, laboratory assessments often represent a static picture of the endocrine or nutritional balance at a certain time point and not the turnover of certain nutrients in the body. As an example, primary hyperparathyroidism is characterized by high serum calcium, which certainly does not reflect the existence of balanced calcium metabolism and body content. Determinations in multiple compartments may be required to reflect nutrients or vitamin content and trafficking.
Overall, the determination of inflammatory markers may offer information for multiple systems (inflammation, nutritional, antioxidant and vitamin status, insulin resistance and level of activity); however, their significance remains to be assessed in clinical practice. For example, increased serum levels of TNF-a may reflect either immune activation with adverse effects on bone health or increased adiposity, which is generally linked with bone protection. Thus additional factors contribute to the net effect on bone homeostasis. Vitamin D has been now implicated in functions related both to bone physiology as well as to immune balance. The vitamin D axis is essential for the assessment of osteoporosis as it interacts with the TNF axis, in addition to its effects on PTH secretion. Furthermore, myopathy is a recognized adverse effect of vitamin D deficiency [50] . Circulating 25(OH)D3 is used for defining nutritional vitamin D status. When considering intestinal calcium absorption, PTH levels and bone density a minimum level of 32 ng/ ml appears necessary for bone health. Optimal nutritional vitamin D status appears be associated with molar ratios of circulating vitamin D and 25(OH)D3 exceeding 0.3, which was found to be reached when circulating 25(OH)D3 was higher than 100 nmol and coincided with the V max of 25-hydroxylase [51 ] . The magnesium-loading test may be used to assess magnesium deficiency in vitamin D-deficient patients with paradoxically low PTH [38 ] . This is an example of an assay, which takes nutrient trafficking and compartmentalization into account, being more informative than simple serum measurements.
Obesity is also associated with alterations in the vitamin D endocrine system. Lower levels of serum 25(OH)D in morbidly obese individuals may be secondary to increased storage in expanded adipose tissue. Percentage of body fat and BMI were negatively correlated with 25(OH)D3 [52, 53] . After correction for 25(OH)D3 no correlation of BMI with 1,25(OH)2D3 was found, reflecting the importance of 25(OH)D3 as the ratelimiting substrate. Furthermore, seasonal variation, with serum 25(OH)D3 and 1,25(OH)2D3 being lowest in January and April and highest in July and October, respectively, needs to be considered. The prevalence of 25(OH)D3 deficiency increased by 70% in subjects with a BMI of more than 30 kg/m 2 , suggesting that obese and morbidly obese individuals may need higher doses of vitamin D supplementation. In this context, assessment of body composition by dual X-ray absorptiometry or computed tomography may be useful. However, the significance of the adiposity for the interpretation of vitamin D levels or for assessing vitamin D requirements in the general population is not yet established.
In addition, recent data may raise questions about the validity of the use of various bone markers for the estimation of bone metabolism in vitamin D-deficient states in diverse ethnic backgrounds. As an example, only minor ethnic differences in markers of bone turnover (osteocalcin, bone-specific alkaline phosphatase and tartrate-resistant acid phosphatase) were detected despite very different prevalences of secondary hyperparathyroidism [54] .
Furthermore, as reviewed by Krause [55] and Schneider and Norman [56] skin alterations due to hormonal or nutritional aberrations (such as acanthosis nigricans and other signs of diabetes mellitus) may offer valuable clinical information for diagnosis. Finally, nutritional assessment tools, such as the Mini-Nutritional Assessment, may direct the diagnostic approach and allow successful nutritional intervention [57] .
Conclusion
Research findings point to complex regulatory mechanisms that have evolved to allow efficient processing of diverse nutritional intakes. In spite of excessive food availability in Western societies, nutritional value is compromised, potentially leading to nutrient and vitamin deficiencies. Nutritional and endocrine balance are tightly linked and their deregulation in the elderly should be studied in parallel. In addition, brain physiology and regulation of appetite may be particularly sensitive in this age group; however, relevant research is still in its infancy. As more comprehensive knowledge is acquired in the field of endocrinology and metabolism novel concepts, which will allow the design of coordinated research and modeled analysis of nutritional and endocrine parameters, should emerge. Healthy lifestyle, appropriate nutrition and exercise, and avoidance of tobacco, drug and alcohol use, or interventions such as appropriately timed hormone-replacement therapy and additional lifestyle measures (e.g. restoration of normal sleep pattern, timely meals, etc.) to restore circadian rhythmicity may result in significant improvements in general health and quality of life and reduce disease-related patient suffering and socioeconomic costs.
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